Company intelligence / Profile preview

UNEEG Medical

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

UNEEG Medical has developed a CE-marked subcutaneous EEG implant system for ultra long-term, objective seizure monitoring in epilepsy patients. The device provides continuous 24/7 brainwave recording for up to 15 months, with data analyzed by proprietary AI software to support disease management. The system is commercially available in Europe and is undergoing pivotal studies for FDA approval in the US. Clinical publications demonstrate its utility for optimizing treatment and improving quality of life for people with epilepsy.

Therapeutic areas: EndocrinologyNeurology
Modalities: DeviceNon-pharmacological therapyDigital health solution (AI-enabled EEG analytics)
Industry: Implantable Medical Devices

Partnerships

Clinical collaborations with leading European centers such as King’s College London and Filadelfia DK

Beyond the preview

Go deeper on UNEEG Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UNEEG Medical.

Explore the full profile